Abiopharma

Transcranial magnetic brain stimulation modulates blepharospasm A randomized controlled study

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001193125-26-353874 <b>Size:</b> 129 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0000950103-26-012471 <b>Size:</b> 315 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001193125-26-353873 <b>Size:</b> 567 KB

Safety of High Frequency rTMS and dTMS with Clozapine: Case Series

Deep transcranial magnetic stimulation for schizoaffective depressive phase

Schlachet Amir 🔴 sold 1.6M shares (2 derivative) of Global-E Online Ltd. (GLBE) at $42.10 ($8.6M) Transaction Date: Aug 13, 2026 | Filing ID: 353602

Different Modalities of Transcranial Magnetic Stimulation to Manage Schizophrenia

Deep transcranial magnetic stimulation over the anterior cingulate cortex in treatment-resistant schizophrenia: A pilot double-blind, randomized controlled trial

(10% Negative) UNITED STATES ANTIMONY CORP (UAMY) Reports Q3 2026 Financial Results

Objective Improvement in ADHD Symptoms Following dTMS to the Right Prefrontal Cortex: Two Cases

Deep rTMS for ADHD

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001213900-26-090686 <b>Size:</b> 268 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023913 <b>Size:</b> 841 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023912 <b>Size:</b> 108 KB